Ken Yamaguchi

36PUBLICATIONS
88CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPacific Peoples health and wellbeing not elsewhere classifiedCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Mar 12, 2026
A Novel CDK12 Inhibitor Induces Homologous Recombination Deficiency to Enhance PARP Inhibitor Efficacy in Uterine Serous Carcinoma.

Shunsuke Kawahara, Mana Taki, Junzo Hamanishi

|Jan 29, 2026
Comparison of nedaplatin and cisplatin in concurrent chemoradiotherapy for cervical cancer: a systematic review and meta-analysis.

Maki Umemiya, Kazuhiro Kou, Yoshihide Inayama

|Jan 27, 2026
HIF2A as a prognostic and clinical therapeutic target in ovarian clear cell carcinoma.

Mengxin Jiang, Ken Yamaguchi, Kohei Hamada

|Jan 23, 2026
Possible overestimation of treatment effects of pelvic and para-aortic lymphadenectomy for early-stage ovarian clear cell carcinoma: a retrospective propensity-score weighted multi-center cohort study.

Naoki Horikawa, Yoshihide Inayama, Miki Otsuki

|Jul 29, 2025
Therapeutic impact of neoadjuvant chemotherapy on lymph node metastasis in locally advanced cervical cancer.

Yuka Mizuta, Koji Yamanoi, Taito Miyamoto

|Jun 27, 2025
Defecation disorder after anterior pelvic exenteration.

Daiki Nishiyama, Sachiko Kitamura, Koji Yamanoi

Pageof 6

Frequent Collaborators

18 joint publications

Masaki Mandai

16 joint publications

Koji Yamanoi

14 joint publications

Junzo Hamanishi

9 joint publications

Mana Taki